INSIDERTERMINAL

High-Impact Form 4 Intelligence

Real-time SEC insider trading data with advanced filtering. Free beta.

💬 Give Feedback

Total Buys (Filtered)

$0

$0

Total Sells (Filtered)

$181K

$181,408

View Raw Line-Items

Live Feed: 2026-03-11

Timeline

Side

Size

All $1M+ $5M+ $10M+

Role

Ticker Search

Clear Clear Filters

Ticker	Company	Reporting Owner	Date	Value (USD)	Type	Form 4
KALV S KalVista Pharmaceuticals, Inc. Yea Christopher • Officer • CHIEF DEVELOPMENT OFFICER Sell to Cover 2026-02-23 $67,669 View Form 4 →
KALV	KalVista Pharmaceuticals, Inc.	Yea Christopher Officer • CHIEF DEVELOPMENT OFFICER Sell to Cover	2026-02-23	$67,669	S	Form 4
KALV S KalVista Pharmaceuticals, Inc. Yea Christopher • Officer • CHIEF DEVELOPMENT OFFICER Sell to Cover 2026-02-18 $16,635 View Form 4 →
KALV	KalVista Pharmaceuticals, Inc.	Yea Christopher Officer • CHIEF DEVELOPMENT OFFICER Sell to Cover	2026-02-18	$16,635	S	Form 4
KALV S KalVista Pharmaceuticals, Inc. Yea Christopher • Officer • CHIEF DEVELOPMENT OFFICER Sell to Cover 2025-11-24 $58,256 View Form 4 →
KALV	KalVista Pharmaceuticals, Inc.	Yea Christopher Officer • CHIEF DEVELOPMENT OFFICER Sell to Cover	2025-11-24	$58,256	S	Form 4
KALV S KalVista Pharmaceuticals, Inc. Yea Christopher • Officer • CHIEF DEVELOPMENT OFFICER Sell to Cover 2025-11-18 $38,848 View Form 4 →
KALV	KalVista Pharmaceuticals, Inc.	Yea Christopher Officer • CHIEF DEVELOPMENT OFFICER Sell to Cover	2025-11-18	$38,848	S	Form 4